TruthArchive.ai - Related Video Feed

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

A study comparing gene profiles of 800 healthy individuals to mRNA-injured individuals found severe genetic dysregulation in the latter. Seven of the injured individuals developed new-onset cancers within a year of mRNA injection, while three experienced cardiovascular or long vaccine syndrome. Gene expression comparisons revealed thousands of dysregulated gene expressions in the mRNA-injured, linked to mitochondrial failure and oncogenic activations. Cancer suppression genes were not being suppressed, and immune dysregulation was observed. The study claims to be the first to show long-term genetic disruptions in the vaccinated, indicating molecular chaos within cells. This may be the biological mechanism behind cardiovascular and carcinogenic issues seen in the vaccinated, possibly due to genomic integration of DNA plasmids from the manufacturing process. The speaker states that this is a landmark report and calls for further investigation into the effects on the population, noting that a large percentage of the global population received COVID vaccines.

The mRNA in vaccines can replicate, including the replication engine, leading to potential spread from person to person. Concerns exist about the inability to stop this replication, with unknown consequences for humanity. The spike protein in these vaccines can be toxic, affecting various tissues. Deployment of this technology in vaccines for humans is already happening, with over 4,000 people injected in Japan.

We compared gene expression profiles across several groups: a healthy control group pre COVID, individuals described as mRNA injured, a group with cancer, and a few individuals who had neurological and cardiovascular adverse events. The analysis showed that in the mRNA injured group, thousands of gene expressions become dysfunctional in several key cellular pathways. Specifically, dysfunction was noted in mitochondrial function, immune function, and protein production. The changes included the production of abnormal proteins as a result of these altered gene expressions. In addition, the analysis reported that cancer surveillance genes were literally turned off in the mRNA injured group. The genes mentioned as turned off include p53, KRAS, and BRCA. This observation is presented as part of the overall pattern of molecular disruption associated with the mRNA injury state. Overall, the findings are described as indicating that flooding the body with synthetic messenger RNA unleashes biochemical havoc. The speaker emphasizes that this biochemical havoc has severe consequences, as evidenced by the observed widespread gene expression dysfunction and the suppression of critical cancer surveillance genes, alongside the production of abnormal proteins and impairments in mitochondrial, immune, and protein production pathways.

The mRNA technology used in vaccines may have hidden gene sequences intentionally designed to create harmful proteins like spider silk, leading to blood clotting. Plasmid contamination in Pfizer's injections could be intentional, allowing for the creation of functional proteins when read backwards. This intentional design raises concerns about nefarious intent behind the vaccine development. Further investigation is needed to determine the extent of potential harm caused by these hidden genes. The delayed discovery of these issues highlights the importance of transparency in medical technologies.

The authors discuss the unusual presence of IgG4 antibodies in mRNA vaccinated individuals, which is not typically seen post-virus infection. IgG4 antibodies are usually associated with parasite infections, allergens, autoimmune diseases, and cancer. The immune system's recognition of repeated antigens can induce IgG4 production, potentially leading to t cell exhaustion and autoimmunity. Scientists are cautious about the implications of IgG4 antibodies and suggest further research comparing outcomes among vaccinated and unvaccinated individuals. This data analysis may reveal any potential clinical impacts over time.

The speaker discusses issues with RNA vaccines, such as frame shifting and template switching, potentially leading to the production of abnormal proteins. They highlight concerns about mitochondrial sequences in vaccines causing adverse effects in patients. The conversation delves into the risks of amyloidogenic proteins and their ability to trigger a chain reaction of misfolding, leading to serious health implications. The speaker emphasizes the need for further research and vigilance in monitoring potential risks associated with RNA vaccines.

A new study indicates mRNA injections induce severe, long-lasting genetic disruption linked to cancer and chronic disease. Comparing gene profiles of mRNA-injured individuals to pre-COVID samples revealed thousands of dysregulated gene expressions linked to mitochondrial failure, suppressed cancer suppression genes, and immune dysregulation. Molecular chaos may result in cardiovascular, neurological, and carcinogenic issues, possibly due to genomic integration of DNA plasmids. A separate study showed mRNA boosters trigger dangerous immune and blood abnormalities, including increased blood clotting and immune suppression, within 48 hours in healthy young adults. Additionally, pets are being used as self-amplifying mRNA vectors via Merck's Nobivac NXT, exposing pet owners to shedding of self-amplifying RNA and toxic antigens. This could potentially cause long-term genetic dysfunction in humans, with the possibility of the synthetic particle recombining with wild viruses. Individuals should ask vets about RNA or mRNA injections for pets and refuse mRNA injections for themselves.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a scientist who sequenced the vaccine in their lab. The DNA is a vector used in the production of the mRNA. The scientist examined vials of the vaccine from a local vaccination program and found DNA in them. This DNA could potentially be linked to rare but serious side effects, such as death from cardiac arrest. It has the ability to integrate into the genomic DNA of cells, potentially causing long-term effects. The presence of this DNA raises concerns about the regulatory process that allowed it to be included in the vaccine. There is a theoretical risk of autoimmune reactions and future cancer development. Further investigation is needed to determine the extent of these risks.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

A study from Lund University in Sweden indicates the Pfizer vaccine can reverse transcribe and install DNA into the human genome within a human liver cell line. This suggests an enzyme can transfer messenger RNA vaccine information into a person's DNA, a process previously claimed impossible. This finding potentially opens the door to lawsuits regarding genetic discrimination (GINA) against individuals who chose not to receive the vaccine. It raises concerns about potential impacts on the DNA of those vaccinated, including pregnant women and their babies. The CDC states that the vaccine will not change a person's DNA, but this new paper suggests otherwise.

This video provides a comprehensive overview of the problems and potential risks associated with mRNA vaccines. The speaker identifies five main issues with the current technology, including dose, pharmacokinetics, localization, fidelity, and innate immunity. They argue that the technology is not yet fully understood or controlled, and that it has been introduced prematurely. The speaker also highlights the lack of tools to measure the production and distribution of the vaccine in the body, as well as potential risks and side effects. They discuss modifications made to the mRNA sequence and how they can impact protein production. The speaker also mentions the potential for immune system suppression and increased risk of infections, parasites, and cancers due to the inhibition of innate immunity. The lack of transparency and proper regulation in the approval process for these vaccines is criticized, and the need for further research and long-term monitoring of their effects is emphasized.

The mRNA platform is effective but has a flaw: it can cause autoimmune disorders by producing foreign proteins in cells. The challenge is to target only specific cells and avoid damage to vital organs. The pandemic allowed the emergency use authorization of mRNA vaccines, bypassing safety measures. However, a large portion of the population has already accepted this technology. To address the issue, a solution could be to replace the spike protein with a different protein that doesn't have flaws. But if the problem lies in any foreign protein transcribed by cells, the immune system may still target vital organs.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a scientist who sequenced the vaccine in his lab. He obtained empty vials from a colleague and found DNA in them. This DNA could potentially cause serious side effects and integrate into the genomic DNA of cells, leading to long-term effects. The scientist is concerned about the regulatory process that allowed this to happen and warns of the risks of genome modification and autoimmune attacks. While the risk of cancer is believed to be rare, it is not zero. Further investigation is needed to determine the extent of these risks.

Yale researchers discovered COVID spike proteins in the blood of individuals who received mRNA vaccines, even up to two years post-vaccination, without prior COVID infection. This raises concerns that the vaccine's genetic material may have integrated with human DNA, leading to ongoing spike protein production. While the findings suggest potential long-term effects, they do not definitively prove genetic integration. The researchers plan to publish their findings on a preprint server and seek validation from an independent lab. These developments could have significant implications for mRNA vaccine safety guidelines affecting over a billion vaccinated individuals. Further details will be shared as the research progresses.

Alden and colleagues found that Pfizer's genetic code can be integrated into the human genome within an hour in a cancerous cell line. This suggests that Pfizer and Moderna's genetic material might become a permanent part of human DNA. There is no study confirming or denying this possibility. The concern is that if eggs or sperm incorporate this genetic code, it could be passed on to future generations. This lack of research is seen as reckless and worrisome.

The Pfizer vaccine contains not only mRNA but also plasma DNA from the vector used in its production. I sequenced samples from two batches of the vaccine in Colombia and found this DNA, which raises concerns about potential health risks. This DNA could integrate into the genomic DNA of cells, leading to permanent changes. Such integration poses theoretical risks, including autoimmune responses and cancer, depending on where the DNA inserts itself in the genome. While these risks may be rare, they warrant investigation to understand their implications better.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The safety of messenger RNA (mRNA) vaccines, such as Pfizer and Moderna, is being questioned. Studies have shown that mRNA can be toxic to heart muscle cells and can remain in the human heart, bloodstream, lymph nodes, and injection site for extended periods. This raises concerns about the safety of mRNA technology for vaccines, as it may make flu shots and other vaccines more dangerous. Some argue for a ban on mRNA development due to the COVID-19 vaccine controversy.

Pfizer and Moderna vaccines use two processes. The first process involves using PCR to amplify and create DNA for clinical trials. Once approved, they use circular bacterial DNA plasmid to replicate billions of mRNA DNA sample copies. However, this resulted in contaminated vaccines with junk DNA. A study found DNA fragments in Pfizer and Moderna vaccines in Ontario, Canada. Researchers tested 27 mRNA vials from 12 different lots and discovered billions to 100 billions of DNA molecules per dose, exceeding FDA and WHO guidelines by 188 to 509 times. This is a significant amount, far beyond what is acceptable.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a researcher who sequenced the vaccine in their lab. The DNA is a vector used in the production of the mRNA. The researcher expressed concern about the potential consequences of this, including rare but serious side effects like death from cardiac arrest. The DNA could integrate into the genomic DNA of cells and become a permanent part of them, posing a risk of genome modification and autoimmune attacks. There is also a theoretical risk of future cancer depending on where the foreign DNA lands in the genome. The researcher believes further investigation is needed to determine if these risks are occurring.

The Pfizer vaccine contains DNA contamination in addition to mRNA. The DNA comes from the DNA vector used as a template for making the mRNA. Sequencing analysis of the vaccine revealed the presence of DNA, which could potentially cause serious side effects and integrate into the genomic DNA of cells. This poses risks such as autoimmune attacks and potential future cancer. The DNA contamination likely occurred during the production process. It is important to investigate if this DNA has integrated into the genomes of vaccinated individuals. The FDA should require Pfizer to remove the DNA from future versions of the vaccine. The regulatory limit for DNA in vaccines is outdated and not suitable for this type of vaccine. It is necessary to address this oversight and ensure the safety of the vaccine.

The discussion reports a comparative analysis of gene expression profiles among four groups: a healthy control group pre-COVID, individuals who were injured by mRNA, and subgroups including three individuals with cancer and a few with neurological and cardiovascular adverse events. The study found that in the mRNA injured group, thousands of gene expressions become dysfunctional, affecting mitochondrial function, immune function, and protein production, leading to the creation of abnormal proteins. It also notes that cancer surveillance genes are literally turned off, specifically mentioning p53 and KRAS, as well as BRCA. The overall claim is that flooding the body with synthetic messenger RNA unleashes biochemical havoc, with severe consequences.

Researchers conducted experiments on mice and humans to investigate the production of antibodies against mistranslated proteins caused by frame shifts in mRNA technology. They found that one-third of the tested individuals had antibodies against these incorrect proteins, indicating their production. The study emphasized the need to address this issue as repeated use of mRNA technology in higher doses could result in the production of numerous incorrect proteins. Additionally, the immune system may attack these proteins, potentially leading to autoimmune responses. The researchers called for further investigation into the impact of these mistranslated proteins on the immune system.

RNA sequencing of the Moderna vaccine's three prime ends suggests a possible mechanism for RNA persistence: in vivo re-adenylation. The data indicates plasmid DNA contamination despite efforts to reduce it. The data also reveals contamination from other mRNA vaccines in Moderna's pipeline. The speaker suggests that with widespread DNA sequencing capabilities, tolerating incorrect RNA sizes in vaccines is irresponsible. Sequencing before approval would have allowed for a better understanding of low RNA scores before global administration.